Zacks.com on MSN2d
BD Stock Rises on Biosero Deal for AI-Powered Robotic Cytometry Tech
BD and Biosero collaborate to integrate robotic automation with flow cytometry technology, aiming to accelerate drug discovery.
BD and Biosero Collaborate to Enable Robotic Integration with Flow Cytometers Used in Drug Discovery and Development
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biosero, a developer of ...
BD And Biosero Partner To Integrate Robotics With Flow Cytometry
BD. (BDX), a global medical technology company, and Biosero, a developer of laboratory automation solutions, Thursday announced that ...
Pharmabiz2d
BD & Biosero collaborate to enable robotic integration with flow cytometers used in drug discovery and development
Franklin Lakes, New Jersey Saturday, January 25, 2025, 10:00 Hrs [IST] ...
Contract Pharma3d
BD, Biosero Partner to Enable Robotic Integration with Flow Cytometers
BD, a global medical technology company, and Biosero, a developer of laboratory automation solutions, have joined forces to ...
Cure Today4d
Understanding the Concept of MRD for Patients With Cancer
Dr. Christopher Flowers discusses MRD testing in cancer care, why this is an important concept to understand and how it ...
News Medical on MSN3d
Microplastics in the bloodstream may pose hidden risks to brain health
Trapped immune cells laden with microplastics starve the brain of oxygen—mouse study links vascular blockages to memory loss and motor deficits, with lingering risks even after symptoms fade.
Becton Dickinson, Biosero announce framework collaboration agreement
Becton, Dickinson and Company and Biosero, a developer of laboratory automation solutions to orchestrate scientific discoveries, announced a ...
pharmaphorum3d
How automating flow cytometry is revolutionising cancer diagnosis and treatment
To support physicians in treating cancer patients, oncology laboratories can benefit from adopting end-to-end automation of flow cytometry workflows. Rapid advances in automation are improving ...
Joplin Globe4d
bioAffinity Technologies Announces Acceptance of Patent Application for Early-Stage Lung Cancer Diagnostic
bioAffinity Technologies Announces Acceptance of Patent Application for Early-Stage Lung Cancer Diagnostic ...
News Medical on MSN2d
Revvity ignites scientific breakthroughs at SLAS2025
Revvity, Inc. is set to unveil its groundbreaking new Phenologic.AI™ software at SLAS2025 in San Diego, January 27-29.
Danaher Gears Up to Post Q4 Earnings: What Lies Ahead for the Stock?
Danaher Corporation DHR is scheduled to release fourth-quarter 2024 results on Jan. 29, before market open. Stay up-to-date ...